| Primary |
| Product Used For Unknown Indication |
45.7% |
| Schizophrenia |
21.9% |
| Schizophrenia, Paranoid Type |
9.2% |
| Psychotic Disorder |
7.2% |
| Schizoaffective Disorder |
3.8% |
| Bipolar Disorder |
2.7% |
| Anxiety |
1.8% |
| Schizophrenia, Disorganised Type |
1.4% |
| Depression |
1.3% |
| Delusional Disorder, Unspecified Type |
0.9% |
| Sleep Disorder |
0.8% |
| Affective Disorder |
0.5% |
| Conduct Disorder |
0.4% |
| Delusion |
0.4% |
| Insomnia |
0.4% |
| Foetal Exposure During Pregnancy |
0.3% |
| Hypertension |
0.3% |
| Personality Disorder |
0.3% |
| Restlessness |
0.3% |
| Schizophrenia, Residual Type |
0.3% |
|
| Psychotic Disorder |
16.7% |
| Suicidal Ideation |
6.9% |
| Weight Increased |
6.4% |
| Depression |
5.9% |
| Schizophrenia |
5.9% |
| Completed Suicide |
5.4% |
| Aggression |
4.9% |
| Inappropriate Schedule Of Drug Administration |
4.9% |
| Weight Decreased |
4.9% |
| Delirium |
4.4% |
| Suicide Attempt |
4.4% |
| Tachycardia |
4.4% |
| Vision Blurred |
3.9% |
| Off Label Use |
3.4% |
| Condition Aggravated |
2.9% |
| Pulmonary Embolism |
2.9% |
| Pyrexia |
2.9% |
| Respiratory Disorder |
2.9% |
| Restlessness |
2.9% |
| Tremor |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
36.1% |
| Schizophrenia |
29.2% |
| Psychotic Disorder |
9.9% |
| Schizophrenia, Paranoid Type |
6.9% |
| Schizoaffective Disorder |
4.9% |
| Bipolar Disorder |
2.4% |
| Delusional Disorder, Unspecified Type |
1.8% |
| Anxiety |
1.6% |
| Depression |
1.3% |
| Schizophrenia, Disorganised Type |
1.3% |
| Personality Disorder |
1.2% |
| Affective Disorder |
0.6% |
| Major Depression |
0.6% |
| Sleep Disorder |
0.6% |
| Restlessness |
0.3% |
| Emotional Disorder |
0.3% |
| Foetal Exposure During Pregnancy |
0.3% |
| Schizoaffective Disorder Depressive Type |
0.3% |
| Conduct Disorder |
0.2% |
| Hypothyroidism |
0.2% |
|
| Psychotic Disorder |
18.9% |
| Suicidal Ideation |
9.0% |
| Weight Increased |
9.0% |
| Inappropriate Schedule Of Drug Administration |
6.1% |
| Renal Impairment |
5.3% |
| Tachycardia |
4.9% |
| Withdrawal Syndrome |
4.9% |
| Condition Aggravated |
4.5% |
| Weight Decreased |
4.5% |
| Delirium |
3.7% |
| Schizophrenia |
3.7% |
| Tremor |
3.7% |
| Hallucination |
3.3% |
| Pain In Extremity |
3.3% |
| Paranoia |
2.9% |
| Suicide Attempt |
2.9% |
| Pyrexia |
2.5% |
| Salivary Hypersecretion |
2.5% |
| Schizoaffective Disorder |
2.5% |
| Aggression |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.5% |
| Schizophrenia |
12.5% |
| Schizophrenia, Disorganised Type |
10.0% |
| Schizophrenia, Paranoid Type |
10.0% |
| Schizoaffective Disorder |
7.5% |
| Anxiety |
2.5% |
| Depression |
2.5% |
| Generalised Anxiety Disorder |
2.5% |
|
| Suicidal Ideation |
23.5% |
| Drug Eruption |
11.8% |
| Psychotic Disorder |
11.8% |
| Death |
5.9% |
| Hyporeflexia |
5.9% |
| Lymphopenia |
5.9% |
| Myocarditis |
5.9% |
| Off Label Use |
5.9% |
| Rash |
5.9% |
| Suicide Attempt |
5.9% |
| Treatment Noncompliance |
5.9% |
| Upper Limb Fracture |
5.9% |
|
